Molecular methods for ehrlichiosis and Lyme disease (Q35623146)

9 August 2017

1 reference

title

Molecular methods for ehrlichiosis and Lyme disease (English)

1 reference

9 August 2017

0 references

J Stephen Dumler

1

1 reference

9 August 2017

publication date

1 December 2003

1 reference

Clinics in laboratory medicine

9 August 2017

published in

1 reference

9 August 2017

volume

23

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

867-84, vi

1 reference

Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

1 reference

7 January 2021

Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Lyme disease-a tick-borne spirochetosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Yield of large-volume blood cultures in patients with early Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Changes in temporal and spatial patterns of outer surface lipoprotein expression generate population heterogeneity and antigenic diversity in the Lyme disease spirochete, Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Borrelia burgdorferi-induced inflammation facilitates spirochete adaptation and variable major protein-like sequence locus recombination

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Evidence that the variable regions of the central domain of VlsE are antigenic during infection with lyme disease spirochetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins: a possible mechanism underlying the expansive host range of Lyme disease spirochetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Comparison of in vitro culture, immunohistochemical staining, and PCR for detection of Borrelia burgdorferi in tissue from experimentally infected animals

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Amplification of Borrelia burgdorferi DNA in skin biopsies from patients with Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B. burgdorferi-specific antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Detection of Borrelia burgdorferi DNA by Polymerase Chain Reaction in Synovial Fluid from Patients with Lyme Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Musculoskeletal manifestations of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Lyme arthritis: lessons learned and to be learned

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Lyme arthritis and post-Lyme disease syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Target imbalance: disparity of Borrelia burgdorferi genetic material in synovial fluid from Lyme arthritis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Neurologic aspects of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Tick bites and Lyme disease in an endemic setting: problematic use of serologic testing and prophylactic antibiotic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Neuroborreliosis: central nervous system involvement.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Central nervous system abnormalities in Lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Laboratory evaluation in the diagnosis of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Detection of Borrelia burgdorferi in cerebrospinal fluid by the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Polymerase chain reaction with the 30-kb circular plasmid of Borrelia burgdorferi B31 as a target for detection of the Lyme borreliosis agents in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Detection of Borrelia burgdorferi by nested polymerase chain reaction in cerebrospinal fluid and urine of children with neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

The polymerase chain reaction in the diagnosis of Lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Comparison of two methods for detecting intrathecal synthesis of Borrelia burgdorferi-specific antibodies and PCR for diagnosis of Lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Evaluation of the polymerase chain reaction for the detection ofBorrelia burgdorferi in cerebrospinal fluid of children with acute peripheral facial palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Value of clinical symptoms, intrathecal specific antibody production and PCR in CSF in the diagnosis of childhood Lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Effective use of polymerase chain reaction for diagnosis of central nervous system infections

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Evaluation of the detection ofBorrelia burgdorferi DNA in urine samples by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Borrelia burgdorferi DNA in the urine of treated patients with chronic Lyme disease symptoms. A PCR study of 97 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Detection of Borrelia burgdorferi DNA by polymerase chain reaction in urine specimens of patients with erythema migrans lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Detection of Borrelia burgdorferi DNA in urine of patients with ocular Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Intralaboratory reliability of serologic and urine testing for Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Human infection with Ehrlichia canis, a leukocytic rickettsia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Prospects for better tuberculosis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

1 reference

7 January 2021

Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Primary isolation of Ehrlichia chaffeensis from patients with febrile illnesses: clinical and molecular characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Human ehrlichiosis in the United States, 1985 to 1990

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Susceptibility of white-tailed deer (Odocoileus virginianus) to infection with Ehrlichia chaffeensis, the etiologic agent of human ehrlichiosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Identification of a p28 gene in Ehrlichia ewingii: evaluation of gene for use as a target for a species-specific PCR diagnostic assay

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

The incidence of ehrlichial and rickettsial infection in patients with unexplained fever and recent history of tick bite in central North Carolina.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Human ehrlichiosis in adults after tick exposure. Diagnosis using polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Transmission and passage in horses of the agent of human granulocytic ehrlichiosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

The human ehrlichioses in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Human granulocytic ehrlichiosis: a case series from a medical center in New York State

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

The emergence of another tickborne infection in the 12-town area around Lyme, Connecticut: human granulocytic ehrlichiosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Reinfection with the agent of human granulocytic ehrlichiosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Direct cultivation of the causative agent of human granulocytic ehrlichiosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Major antigenic proteins of the agent of human granulocytic ehrlichiosis are encoded by members of a multigene family.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

ankA: an Ehrlichia phagocytophila group gene encoding a cytoplasmic protein antigen with ankyrin repeats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Genetic variability and stability of Anaplasma phagocytophila msp2 (p44).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Ehrlichia ewingii infection in white-tailed deer (Odocoileus virginianus).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

Granulocytic ehrlichiosis in dogs from North Carolina and Virginia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

A molecular and serologic survey of Ehrlichia canis, E. chaffeensis, and E. ewingii in dogs and ticks from Oklahoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900080-5

7 January 2021

10.1016/S0272-2712(03)00080-5

Identifiers

DOI

1 reference

release_rfqa35jl2fgdvc2hptlq6bs6by

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rfqa35jl2fgdvc2hptlq6bs6by

24 November 2022

mapped directly with Wikidata item

1 reference